Switch to:
Also traded in: Germany, Japan
» Details

Insider Trades

Latest Guru Trades with OCPNY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies  
Compare:NYSE:MTD, NYSE:WAT, OTCPK:TRUMY, NAS:HOLX, NYSE:RMD, NYSE:COO, NAS:XRAY, OTCPK:CLPBY, NYSE:BCR, OTCPK:SAUHY, NYSE:WST, NYSE:STE, NYSE:HRC, OTCPK:GNGBY, NYSE:CMD, NAS:ICUI, NAS:PODD, OTCPK:ANSLY, NYSE:HAE, NYSE:HYH » details
Traded in other countries:OLY1.Germany, 7733.Japan,
Olympus Corp is engaged in the manufacture and sale of precision machineries and instruments.

Olympus Corp was incorporated in Japan on October 12, 1919. The Company is engaged in manufacturing and selling of precision machineries and instruments. The Company operates in four segments including Medical Business, Life Science and Industrial Business, Imaging Business, and Others. The Medical Business segment is engaged in manufacturing & selling of medical endoscopes, surgical endoscopes, endotherapy devices and other products including endoscopy systems includes videoscopes, video processors, light sources, and liquid crystal display (LCD) panels; peripheral equipment including image recording device, endoscope cleaning systems, and sterilization systems; surgical devices including surgical video endoscopy systems, peripheral devices for endoscopic surgery, and electrosurgical knives. The Life Science and Industrial Business segment is engaged in the manufacturing & selling of biological microscopes, industrial microscopes, industrial endoscopes, non-destructive testing equipment and other products. The Imaging Business segment is engaged in manufacturing and selling of digital cameras, voice recorders and other products. The Others business segment manufactures and sells biomedical materials and conducts system development and other business activities.

Ratios

vs
industry
vs
history
PE Ratio 22.14
OCPNY's PE Ratio is ranked higher than
68% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.87 vs. OCPNY: 22.14 )
Ranked among companies with meaningful PE Ratio only.
OCPNY' s PE Ratio Range Over the Past 10 Years
Min: 7.91  Med: 36.72 Max: 758.27
Current: 22.14
7.91
758.27
PE Ratio without NRI 22.14
OCPNY's PE Ratio without NRI is ranked higher than
66% of the 115 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.49 vs. OCPNY: 22.14 )
Ranked among companies with meaningful PE Ratio without NRI only.
OCPNY' s PE Ratio without NRI Range Over the Past 10 Years
Min: 7.91  Med: 36.72 Max: 758.27
Current: 22.14
7.91
758.27
Price-to-Owner-Earnings 35.77
OCPNY's Price-to-Owner-Earnings is ranked lower than
63% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.26 vs. OCPNY: 35.77 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
OCPNY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 29.15  Med: 52.49 Max: 733.65
Current: 35.77
29.15
733.65
PB Ratio 3.18
OCPNY's PB Ratio is ranked higher than
54% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.45 vs. OCPNY: 3.18 )
Ranked among companies with meaningful PB Ratio only.
OCPNY' s PB Ratio Range Over the Past 10 Years
Min: 1.48  Med: 3.83 Max: 20.67
Current: 3.18
1.48
20.67
PS Ratio 1.81
OCPNY's PS Ratio is ranked higher than
67% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.96 vs. OCPNY: 1.81 )
Ranked among companies with meaningful PS Ratio only.
OCPNY' s PS Ratio Range Over the Past 10 Years
Min: 0.15  Med: 0.92 Max: 3.12
Current: 1.81
0.15
3.12
EV-to-EBIT 20.34
OCPNY's EV-to-EBIT is ranked higher than
64% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.36 vs. OCPNY: 20.34 )
Ranked among companies with meaningful EV-to-EBIT only.
OCPNY' s EV-to-EBIT Range Over the Past 10 Years
Min: -70.2  Med: 32.25 Max: 461.4
Current: 20.34
-70.2
461.4
EV-to-EBITDA 20.34
OCPNY's EV-to-EBITDA is ranked lower than
59% of the 129 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.65 vs. OCPNY: 20.34 )
Ranked among companies with meaningful EV-to-EBITDA only.
OCPNY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.6  Med: 30.5 Max: 461.4
Current: 20.34
6.6
461.4
PEG Ratio 6.47
OCPNY's PEG Ratio is ranked lower than
82% of the 56 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. OCPNY: 6.47 )
Ranked among companies with meaningful PEG Ratio only.
OCPNY' s PEG Ratio Range Over the Past 10 Years
Min: 0.6  Med: 1.44 Max: 16.55
Current: 6.47
0.6
16.55
Shiller PE Ratio 82.85
OCPNY's Shiller PE Ratio is ranked lower than
85% of the 47 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 41.26 vs. OCPNY: 82.85 )
Ranked among companies with meaningful Shiller PE Ratio only.
OCPNY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 64.94  Med: 79.46 Max: 91.06
Current: 82.85
64.94
91.06
Current Ratio 1.97
OCPNY's Current Ratio is ranked lower than
62% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.39 vs. OCPNY: 1.97 )
Ranked among companies with meaningful Current Ratio only.
OCPNY' s Current Ratio Range Over the Past 10 Years
Min: 1.39  Med: 1.7 Max: 2.16
Current: 1.97
1.39
2.16
Quick Ratio 1.48
OCPNY's Quick Ratio is ranked lower than
56% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. OCPNY: 1.48 )
Ranked among companies with meaningful Quick Ratio only.
OCPNY' s Quick Ratio Range Over the Past 10 Years
Min: 1.11  Med: 1.38 Max: 1.75
Current: 1.48
1.11
1.75
Days Inventory 169.93
OCPNY's Days Inventory is ranked lower than
73% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 123.69 vs. OCPNY: 169.93 )
Ranked among companies with meaningful Days Inventory only.
OCPNY' s Days Inventory Range Over the Past 10 Years
Min: 54.63  Med: 74.84 Max: 169.93
Current: 169.93
54.63
169.93

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.48
OCPNY's Dividend Yield % is ranked lower than
85% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.25 vs. OCPNY: 0.48 )
Ranked among companies with meaningful Dividend Yield % only.
OCPNY' s Dividend Yield % Range Over the Past 10 Years
Min: 0.2  Med: 0.54 Max: 3.26
Current: 0.48
0.2
3.26
Dividend Payout Ratio 0.10
OCPNY's Dividend Payout Ratio is ranked higher than
92% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. OCPNY: 0.10 )
Ranked among companies with meaningful Dividend Payout Ratio only.
OCPNY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09  Med: 0.16 Max: 2.09
Current: 0.1
0.09
2.09
Forward Dividend Yield % 0.71
OCPNY's Forward Dividend Yield % is ranked lower than
80% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. OCPNY: 0.71 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.48
OCPNY's 5-Year Yield-on-Cost % is ranked lower than
85% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.99 vs. OCPNY: 0.48 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
OCPNY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.2  Med: 0.54 Max: 3.26
Current: 0.48
0.2
3.26
3-Year Average Share Buyback Ratio -4.30
OCPNY's 3-Year Average Share Buyback Ratio is ranked lower than
58% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.80 vs. OCPNY: -4.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OCPNY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.6  Med: -0.45 Max: 0.5
Current: -4.3
-8.6
0.5

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 4.82
OCPNY's Price-to-Tangible-Book is ranked higher than
50% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.64 vs. OCPNY: 4.82 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
OCPNY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.75  Med: 6.98 Max: 9.47
Current: 4.82
4.75
9.47
Price-to-Intrinsic-Value-Projected-FCF 3.89
OCPNY's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
76% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. OCPNY: 3.89 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
OCPNY' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 3.4  Med: 3.9 Max: 4.92
Current: 3.89
3.4
4.92
Price-to-Median-PS-Value 1.98
OCPNY's Price-to-Median-PS-Value is ranked lower than
84% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. OCPNY: 1.98 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
OCPNY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35  Med: 1.02 Max: 3.21
Current: 1.98
0.35
3.21
Price-to-Peter-Lynch-Fair-Value 0.89
OCPNY's Price-to-Peter-Lynch-Fair-Value is ranked higher than
86% of the 35 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.80 vs. OCPNY: 0.89 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
OCPNY' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.87  Med: 1.7 Max: 147.01
Current: 0.89
0.87
147.01
Price-to-Graham-Number 2.18
OCPNY's Price-to-Graham-Number is ranked higher than
61% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. OCPNY: 2.18 )
Ranked among companies with meaningful Price-to-Graham-Number only.
OCPNY' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 2.15  Med: 3.22 Max: 15.43
Current: 2.18
2.15
15.43
Earnings Yield (Greenblatt) % 4.97
OCPNY's Earnings Yield (Greenblatt) % is ranked higher than
78% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.80 vs. OCPNY: 4.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
OCPNY' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.2  Med: 2.7 Max: 9.8
Current: 4.97
0.2
9.8
Forward Rate of Return (Yacktman) % 36.03
OCPNY's Forward Rate of Return (Yacktman) % is ranked higher than
94% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.86 vs. OCPNY: 36.03 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
OCPNY' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -39.6  Med: -26.65 Max: 36.03
Current: 36.03
-39.6
36.03

More Statistics

Revenue (TTM) (Mil) $6,842
EPS (TTM) $ 1.62
Beta0.85
Short Percentage of Float0.00%
52-Week Range $31.50 - 42.02
Shares Outstanding (Mil)342.23
» More Articles for OTCPK:OCPNY

Headlines

Articles On GuruFocus.com
David Herro Gains 2 New Holdings, Divests Another Dec 13 2016 
David Herro Comments on Olympus Oct 10 2016 
David Herro's Oakmark International Fund 3rd Quarter 2016 Oct 10 2016 
David Herro Comments on Olympus Oct 07 2014 
David Herro's Oakmark International Fund Third Quarter 2014 Letter Oct 07 2014 
T. Rowe Price Japan Fund’s Top 5 New Buys Jul 17 2013 
David Herro Comments on Olympus Corp. Apr 23 2013 
David Herro's Oakmark International Fund Q1 2013 Commentary Apr 23 2013 
Olympus' Efforts to Improve Corporate Governance Leave Room for More Sep 28 2012 

More From Other Websites
Olympus Corp. :OCPNY-US: Earnings Analysis: Q3, 2017 By the Numbers : February 3, 2017 Feb 03 2017
ETFs with exposure to Olympus Corp. : December 13, 2016 Dec 13 2016
ETFs with exposure to Olympus Corp. : November 30, 2016 Nov 30 2016
ETF’s with exposure to Olympus Corp. : November 4, 2016 Nov 04 2016
Olympus Corp. :OCPNY-US: Earnings Analysis: Q2, 2017 By the Numbers : November 3, 2016 Nov 03 2016
Olympus Corp's (TYO:7733) First Three Vanta(TM) Portable XRF Analyzers Purchased by CSIRO Sep 22 2016
ETF’s with exposure to Olympus Corp. : September 15, 2016 Sep 15 2016
ETF’s with exposure to Olympus Corp. : September 1, 2016 Sep 01 2016
ETF’s with exposure to Olympus Corp. : August 12, 2016 Aug 12 2016
Olympus Corp. :OCPNY-US: Earnings Analysis: Q1, 2017 By the Numbers : August 8, 2016 Aug 08 2016
Zacks.com featured highlights: Apogee Enterprises, AMN Healthcare Services, Gibraltar Industries,... Jul 29 2016
Look Beyond Earnings: 5 Stocks with Increasing Cash Flows Jul 28 2016
5 Low Beta Stocks to Protect Your Gains Jul 20 2016
The Zacks Analyst Blog Highlights: Honda Motor, Toyota Motor, Canon and Olympus Jul 14 2016
4 Stocks That Will Benefit from a Weaker Yen Jul 13 2016
Olympus Corporation of the Americas Enters Into US And Canada Distribution Agreement With Arc... May 06 2016
European Stock Markets Fall Before U.S. Jobs Data May 06 2016
Olympus Corp. :OCPNY-US: Earnings Analysis: Q4, 2016 By the Numbers May 04 2016
[video]Olympus Teams Up With Sony for Surgical Big Screen TV Apr 09 2016
Whistleblower Delivers A Triple Whammy To Olympus; More Companies Might Get Hit Mar 04 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK